Artificial Intelligence

The study finds AI is rapidly transforming entry-level roles, with employers increasingly prioritising adaptability, AI fluency and human-centric skills over traditional expertise

V Anantha Nageswaran said businesses must prioritise resilience over efficiency as geopolitical tensions rise, while arguing that AI will increase, not reduce, human cognitive load

Coforge aims to reach $5 billion in revenue within four years, banking on AI-driven demand while viewing LLM firms as partners rather than competitors

The working group will guide insurers on AI adoption, governance and oversight while ensuring policyholder interests and data protection remain safeguarded

AI is rapidly evolving into a mainstream workforce capability, with non-technical professionals and learners from Tier-II cities driving adoption, career growth and salary gains

Announcing the Midjourney Scanner, startup CEO David Holz said that no such device has ever been built until now, touting the new technology as superior to MRI in numerous ways

India AI Workforce Report 2026 finds AI learning spreading beyond metros, engineering backgrounds and traditional tech roles

AI is expanding beyond engineering roles, driving salary growth, leadership opportunities and wider participation from women and professionals in Tier-II cities, says Scaler report

The estimates are based on survey data in February involving more than 23,000 US workers, including 660 respondents who reported being unemployed after their jobs were eliminated

Emily Dalton Smith, who has been with the Facebook owner since 2015, previously held roles as vice president of product management and head of product for Meta's Twitter-like microblogging app Threads

Partnership includes an 8.2 per cent stake acquisition and a joint venture to develop hyperscale datacenter campuses across India amid rising AI and cloud demand

RIL's annual report, according to CLSA, highlights the company's ambition to leverage AI offerings, plans to expand data centre capacity, along with progress in new energy.

AI verification startup plans to use proceeds to train formalisation models, expand research team and scale operations across regulated sectors

Sarvam AI has become a unicorn after raising $234 million in a Series B funding round. The round was led by HCLTech and Bessemer Venture Partners, with participation from existing investors Khosla Ven

India has emerged as one of Asia Pacific region's most AI-ready healthcare markets, with 78 per cent of consumers using GenAI to better understand diagnoses and treatment options, according to a report by Bain & Company. Healthcare systems in Asia-Pacific are facing growing strain as rising patient expectations collide with a stretched clinical workforce, accelerating the shift toward new care models and AI-enabled support, said the report titled '2026 Asia-Pacific Front Line of Healthcare Report'. Consumers across Asia-Pacific are increasingly taking a proactive role in managing their health while expecting more convenience, responsiveness and coordination from the healthcare system, it said. As per the report, 84 per cent of consumers expect greater convenience from the healthcare system, while 71 per cent expect doctors to be more responsive through channels such as phone, WhatsApp or email. Three out of five consumers now also schedule regular checkups and screenings, compared

SpaceX formally agreed to buy Cursor Tuesday in an all-stock deal that values the company at $60 billion

The letter ordered Anthropic not to give its Fable 5 and Mythos 5 artificial intelligence models to foreign nationals anywhere in the world without a license from the Commerce Department

Today's opinions explore India's external vulnerabilities, the concentration of global capital in US technology, energy reforms, disclosure norms, and a nuanced portrait of Kashmir through the Chenab

Brokerages see strategic benefits from HCL Tech's investment in Sarvam, though long-term returns will depend on the AI firm's ability to scale and execute effectively

Brokerage says India should focus on specialty medicines and incremental innovation rather than copying Big Pharma's new-drug discovery model